Bioscience Valuation
Joachim Greuel is a highly experienced professional in the fields of finance, healthcare management, and biotechnology. Currently serving as Managing Director at Bioscience Valuation since October 2000, Joachim has held various notable positions, including Professor of Finance and Healthcare Management at IE Business School (2011-2013) and Investment Manager at NMT New Medical Technologies AG (1998-2000). Previous experience includes roles as a Senior Strategy Consultant at Accenture (1995-1997) and Head of Neurophysiological Research at Bayer (1988-1993). Joachim holds an MBA in Finance and Healthcare Management from The Wharton School and a Ph.D. in Physiology from the Max-Planck-Institute for Brain Research and Eberhard Karls University of Tübingen, along with a Master/Diplom in Biology from The Philipp University of Marburg.
This person is not in any teams
Bioscience Valuation
Bioscience Valuation (BSV) is a globally operating boutique life sciences consulting company. We serve all private and public entities involved in the life sciences – including biotech and pharma companies, investment funds, and research organizations. At the time of our inception, we were pioneers in our field. Foundational papers authored by our co-founders now form the cornerstone of valuation methods taught at the world’s leading business schools. Today, we’ve evolved into a full-grown service provider addressing the needs of all organizations active in the life sciences. We are headquartered in the Munich Metropolitan Region and serve clients on all continents. Please don't hesitate to reach out!